Abstract:Higher sensitivity of pericardial fluid cytology than biopsy in malignant effusions. Lung adenocarcinoma is the most common type in malignant pericardial effusion. A multi‐institutional study reviewed 309 cases of pericardial fluid cytology and pericardial biopsy, highlighting greater sensitivity of cytology (84.8%) with the most common primaries being lung, breast, gastrointestinal, and haematologic origin. The study also commented on the impact of ancillary testing, volume of pericardial fluid submitted for analysis, and utilization of molecular diagnostics like cfDNA methylation analysis for further enhancement of diagnostic accuracy and improved patient outcomes. Objective Malignant pericardial effusions are associated with a poor prognosis. Pericardial fluid cytology and pericardial biopsy are the primary methods for diagnosis. This study aimed to conduct a multi‐institutional analysis to compare the diagnostic sensitivity of cytology and biopsy, and to investigate potential explanations for false‐negative results in cytology. Methods A retrospective review of pericardial fluid cytology cases with concurrent biopsy was conducted across four different institutions. Results were compared using standard statistical methods with attention to sensitivity and histologic distribution. False‐negative cytology cases were investigated for further exploration. Results A total of 309 cases were collected, of which 99 (32.0%) were confirmed malignant through repeat sampling or clinical history. Pericardial fluid cytology and biopsy identified 84 and 64 malignant cases, respectively. Our findings confirmed significantly higher sensitivity of cytology compared to biopsy (84.8% vs 65.7%). The most common sites of origin were lung, breast, and gastrointestinal, with adenocarcinoma being the most prevalent histologic subtype. Histologic review of 12 false‐negative cytology cases revealed three key explanations; lymphoma was the most common missed diagnosis (33.3%); fibrinous pericarditis obscures neoplastic cells on the pericardial surface; and pericardial involvement can be seen without extension into the pericardial space. Conclusion This study demonstrated diagnostic superiority of pericardial fluid cytology over biopsy in the evaluation of malignant pericardial effusions. We identified several limitations in fluid cytology causing false negatives. In the context of an underlying malignancy with pericardial effusion, pathologists should consider immunohistochemistry studies to aid on the diagnosis.

The Cytological Diagnosis of a Malignant Effusion Is Independent of the Volume of Fluid Processed

Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology

The study of pleural lavage cytology for lung cancer

Clinical and laboratory characteristics of lymphoid neoplasms in serous effusions: a single centre experience in China

Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis

Diagnostic accuracy of International System for Reporting Serous Fluid Cytopathology: A systematic review and meta‐analysis in malignancy diagnosis

Clinical and cytopathologic characteristics of lymphoid neoplasms involved with serous effusions: a single center experience

Diagnosis and categorization of malignant effusions: A 6‐year review from a single academic institution

Role of Ancillary Techniques in Reporting Serous Fluid Cytology – “Redefining Categories, Refining Diagnosis”

Diagnostic Accuracy of Cancer in Pleural Effusion: A Combination Serum Tumor Markers and Cytology

Higher sensitivity of pericardial fluid cytology than biopsy in malignant effusions with potential explanation of false‐negative cytology: A multi‐institutional analysis

Sensitivity of Initial Thoracentesis for Malignant Pleural Effusion Stratified by Tumor Type in Patients with Strong Evidence of Metastatic Disease

Impact of serous fluid volume on next-generation sequencing: a significant step forward for optimization of serous fluid sample collection

Re‐Categorization and Risk of Malignancy of Atypical Effusions According to the International System for Reporting Serous Fluid Cytopathology (TIS): An Institutional Experience

Clinical and cytological characteristics of serous effusions in 69 cases of lymphoma patients

Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas

Diagnostic Value of Thin-Cytological Test and Routine Cytological Detection for Patients

Diagnosis of Serous Effusion with Intelligent Imaging Flow Cytometry

Pleural fluid analysis of lung cancer vs benign inflammatory disease patients

Risk of malignancy in effusions according to the International System for Serous Fluid Cytopathology: a review.

Clinical Analysis of 172 Cases of Malignant Pleural Effusion with Lung Cancer